Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.

Bone morphogenetic proteins (BMPs) act as central regulators of ovarian physiology and may be involved in ovarian cancer development. In an effort to understand these processes, we characterized transforming growth factor beta/BMP receptor and Smad expression in immortalized ovarian surface epithelial cells and a panel of ovarian cancer cell lines. These studies prompted us to evaluate the potential role of BMP9 signaling in ovarian cancer. Using small interfering RNA, ligand trap, inhibitor, and ligand stimulation approaches, we show that BMP9 acts as a proliferative factor for immortalized ovarian surface epithelial cells and ovarian cancer cell lines, signaling predominantly through an ALK2/Smad1/Smad4 pathway rather than through ALK1, the major BMP9 receptor in endothelial cells. Importantly, we find that some ovarian cancer cell lines have gained autocrine BMP9 signaling that is required for proliferation. Furthermore, immunohistochemistry analysis of an ovarian cancer tissue microarray reveals that approximately 25% of epithelial ovarian cancers express BMP9, whereas normal human ovarian surface epithelial specimens do not. Our data indicate that BMP9 signaling through ALK2 may be a novel therapeutic target in ovarian cancer.

[1]  M. Follettie,et al.  Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Charles C Hong,et al.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.

[3]  W. E. Gye,et al.  CANCER RESEARCH , 1923, British medical journal.

[4]  M. Nachtigal,et al.  Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. , 2008, Gene.

[5]  J. Inman,et al.  Bmc Cell Biology a Rapid and Sensitive Bioassay for the Simultaneous Measurement of Multiple Bone Morphogenetic Proteins. Identification and Quantification of Bmp4, Bmp6 and Bmp9 in Bovine and Human Serum , 2022 .

[6]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[7]  Mallika Singh,et al.  Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.

[8]  S. Ross,et al.  How the Smads regulate transcription. , 2008, The international journal of biochemistry & cell biology.

[9]  V. Rosen,et al.  Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. , 1995, Endocrinology.

[10]  K. Miyazono,et al.  Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. , 1993, Oncogene.

[11]  P. G. Knight,et al.  FOCUS ON TGF-? SIGNALLING: TGF-B SUPERFAMILY MEMBERS AND OVARIAN FOLLICLE DEVELOPMENT , 2006 .

[12]  C. Hill,et al.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.

[13]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[14]  L. David,et al.  Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.

[15]  R. Thies,et al.  Bone Morphogenetic Protein-9 , 2000, The Journal of Biological Chemistry.

[16]  Y. Sasai,et al.  Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4 , 1996, Cell.

[17]  Phil G Knight,et al.  TGF-beta superfamily members and ovarian follicle development. , 2006, Reproduction.

[18]  D. Katsaros,et al.  Chordin is underexpressed in ovarian tumors and reduces tumor cell motility , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  A. Phongdara,et al.  Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones. , 2006, International journal of oral and maxillofacial surgery.

[20]  Mallika Singh,et al.  An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis , 2003, Nature Biotechnology.

[21]  F. Otsuka,et al.  The role of bone morphogenetic proteins in ovarian function. , 2019, Reproduction (Cambridge, England) Supplement.

[22]  T J Hudson,et al.  Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer , 2006, British Journal of Cancer.

[23]  P. ten Dijke,et al.  Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.

[24]  L. Dubeau,et al.  The cell of origin of ovarian epithelial tumours. , 2008, The Lancet. Oncology.

[25]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[26]  P. Leung,et al.  Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.

[27]  K. Miyazono,et al.  Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[28]  C. Le Page,et al.  BMP-2 signaling in ovarian cancer and its association with poor prognosis , 2009, Journal of ovarian research.

[29]  E. Beutler,et al.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 , 2006, Proceedings of the National Academy of Sciences.

[30]  M. Nachtigal,et al.  Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. , 2003, Endocrinology.

[31]  Manas Kumar Majumdar,et al.  BMP‐2 and BMP‐9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL‐1 , 2001, Journal of cellular physiology.

[32]  R. Curi,et al.  Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. , 2008, Endocrinology.

[33]  Li-Xin Xiang,et al.  Bone morphogenetic protein. , 2007, Biochemical and biophysical research communications.

[34]  Gerard C Blobe,et al.  Role of transforming growth factor-beta superfamily signaling pathways in human disease. , 2008, Biochimica et biophysica acta.

[35]  M. Goumans,et al.  Controlling cell fate by bone morphogenetic protein receptors , 2003, Molecular and Cellular Endocrinology.

[36]  J. Blusztajn,et al.  Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. , 2000, Science.

[37]  L. Spender,et al.  TGF-β induces apoptosis in human B cells via transcriptional regulation of BIK and BCL-XL , 2009, Cell Death and Differentiation.